Your Guide to the 2026 Medicare Drug Price Changes

If you’re on Medicare, you may have heard that big changes are coming to prescription drug costs. You clicked here to find out if your medications will be cheaper in 2026, and this guide will give you the clear, straightforward answers you need. Let’s walk through exactly what’s happening and how to check your prescriptions.

Understanding the New Medicare Drug Negotiations

For the first time, a new law allows Medicare to negotiate directly with drug companies to lower the prices of certain high-cost prescription drugs. This program is part of the Inflation Reduction Act of 2022, and it’s designed to make essential medications more affordable for millions of seniors.

The process works in phases. Each year, the Centers for Medicare & Medicaid Services (CMS) will select a new list of drugs for negotiation. The first round of negotiations is already underway, and the new, lower prices for the first group of selected drugs will officially take effect on January 1, 2026.

This is a significant shift. In the past, Medicare was prohibited from negotiating drug prices. This new authority aims to reduce out-of-pocket costs for beneficiaries and save taxpayers money. The selection process focuses on drugs that are widely used by Medicare recipients, have been on the market for several years without generic competition, and account for a large portion of Medicare spending.

The First 10 Drugs with Lower Prices in 2026

This is the most important part of the puzzle: the specific list of medications. The government has announced the first 10 drugs covered under Medicare Part D that were selected for price negotiation. If you take any of the medications listed below, you can expect to see a lower price for them starting in 2026.

Here is the official list. We have included the brand name and what each medication is generally used for to help you easily identify if yours is included.

• Eliquis (apixaban): Used to prevent blood clots and reduce the risk of stroke in people with atrial fibrillation.
• Jardiance (empagliflozin): Used to treat type 2 diabetes and reduce the risk of cardiovascular death in adults with heart failure.
• Xarelto (rivaroxaban): Another common medication used to prevent and treat blood clots.
• Januvia (sitagliptin): Used to help control blood sugar levels in adults with type 2 diabetes.
• Farxiga (dapagliflozin): Used to treat type 2 diabetes, heart failure, and chronic kidney disease.
• Entresto (sacubitril/valsartan): A combination medication used to treat certain types of heart failure.
• Enbrel (etanercept): Used to treat rheumatoid arthritis, psoriatic arthritis, and other autoimmune conditions.
• Imbruvica (ibrutinib): A targeted therapy used to treat certain types of blood cancers, including mantle cell lymphoma and chronic lymphocytic leukemia.
• Stelara (ustekinumab): Used to treat psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis.
• Fiasp; Novolog (insulin aspart): A fast-acting insulin product used to manage blood sugar levels in people with type 1 and type 2 diabetes. This includes various forms like FlexPen and PenFill.

Check your prescription bottles or your online pharmacy account. If the name of your medication matches one on this list, it is part of this first group set for a price reduction.

What Happens Next and When Will You See Savings?

Seeing your medication on the list is the first step. The next question is, what does this actually mean for your wallet?

The negotiation process is happening now between the government and the drug manufacturers. The final, new “maximum fair price” for each of these 10 drugs must be published by September 1, 2024. This will be the new, lower price that Medicare and its beneficiaries will pay.

These new prices will then go into effect on January 1, 2026. So, while you won’t see the savings immediately, you now have a clear timeline of when to expect the cost of these specific medications to go down. When you fill your prescriptions for these drugs in 2026, the price you pay at the pharmacy should reflect this new negotiated rate.

The Future of the Program: More Drugs Are Coming

This initial list of 10 drugs is just the beginning. The Inflation Reduction Act has laid out a plan to expand the program over the next several years. Here is a look at the schedule for adding more drugs to the negotiation list:

• For 2027: An additional 15 Medicare Part D drugs will be selected.
• For 2028: Another 15 drugs will be selected, which may include both Part D and Part B drugs (medications often administered in a doctor’s office).
• For 2029 and beyond: 20 new drugs will be selected for negotiation each year.

This means that even if your medication isn’t on the first list, it could be selected in a future year. This program is designed to have a long-term impact on the affordability of prescription drugs for the entire Medicare population.

Other Major Cost-Saving Changes for Medicare Beneficiaries

The drug price negotiation is a headline feature, but it’s not the only way the law is helping to lower your healthcare costs. There are other critical provisions you should be aware of:

• $2,000 Out-of-Pocket Cap: Starting in 2025, there will be a new $2,000 annual cap on what you have to pay out-of-pocket for prescription drugs covered under Medicare Part D. This is a massive change that will provide a financial safety net for people with very high drug costs. Once you spend $2,000, you will pay $0 for your covered drugs for the rest of the year.
• Capped Insulin Costs: The cost of a one-month supply of any Medicare-covered insulin product is already capped at $35. This has been in effect since 2023 and provides significant relief for millions of Americans with diabetes.
• Free Recommended Vaccines: Recommended adult vaccines, like the shingles vaccine (Shingrix), are now available at no cost to you if you have Medicare Part D.

These changes work together to create a more predictable and affordable experience for managing your health on Medicare.

Frequently Asked Questions

What if my drug isn’t on the list of 10? If your medication is not on the initial list, its price will not be affected by the 2026 negotiations. However, it could be selected for negotiation in a future year. It is still wise to review your Medicare Part D plan every year during the Open Enrollment Period (October 15 to December 7) to ensure you have the best coverage for your specific prescriptions.

Does this price negotiation apply to Medicare Advantage plans? Yes. The new negotiated prices will apply to all drugs covered under Medicare Part D. This includes standalone Part D prescription drug plans as well as the drug coverage that is integrated into most Medicare Advantage plans (MA-PDs).

Where can I find the official information? The most reliable source for information on this program is the official Medicare website at Medicare.gov or the CMS.gov website. They provide updates on the negotiation process and other Medicare benefits.